Atypical plasma lipid profile in cancer patients: Cause or consequence?

Biochimie

Volumn 102, Issue 1, 2014, Pages 9-18

  Munir, Rimsha ^a   Usman, Hina ^a   Hasnain, Shahida ^a   Smans, Karine ^b   Kalbacher, Hubert ^c   Zaidi, Nousheen ^a  

^a UNIVERSITY OF THE PUNJAB   (Pakistan)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cancer; Lipoproteins; Plasma lipids; Serum lipids

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; CHYLOMICRON; HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; BREAST CANCER; BREAST CARCINOMA; CANCER PATIENT; CANCER RISK; CARCINOGENESIS; CHILDHOOD LEUKEMIA; CHOLESTEROL BLOOD LEVEL; COLON CANCER; COLORECTAL ADENOMA; COLORECTAL CANCER; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; HEAD AND NECK CANCER; HUMAN; INTRADUCTAL CARCINOMA; LEUKOPLAKIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; LIVER CANCER; LUNG CANCER; LUNG SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; MOUTH CANCER; MOUTH SQUAMOUS CELL CARCINOMA; NONHODGKIN LYMPHOMA; OVARY CANCER; OVARY CARCINOMA; PANCREAS CANCER; PRECANCER; PROSTATE CANCER; REVIEW; RISK FACTOR; STOMACH CANCER; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CLASSIFICATION; NEOPLASM; PATHOLOGY; PROSPECTIVE STUDY;

CHOLESTEROL, HDL; HUMANS; LIPOPROTEINS; NEOPLASMS; PROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 84901812272     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2014.03.010     Document Type: Short Survey

References (126)

1. R.A. Hegele Plasma lipoproteins: genetic influences and clinical implications Nat. Rev. Genet. 10 2009 109 121
2. J. Incardona, and H. Roelink The role of cholesterol in Shh signaling and teratogen-induced holoprosencephaly Cell. Mol. Life Sci. CMLS 57 2000 1709 1719
3. S.M. Grundy Obesity, metabolic syndrome, and cardiovascular disease J. Clin. Endocrinol. Metab. 89 2004 2595 2600
4. C.K. Glass, and J.L. Witztum Atherosclerosis: the road ahead review Cell 104 2001 503 516
5. P.P. Hsu, and D.M. Sabatini Cancer cell metabolism: Warburg and beyond Cell 134 2008 703 707
6. E. Rysman, K. Brusselmans, K. Scheys, L. Timmermans, R. Derua, S. Munck, P.P. Van Veldhoven, D. Waltregny, V.W. Daniëls, and J. Machiels De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation Cancer Res. 70 2010 8117 8126
7. J.E. Vance, and D.E. Vance Biochemistry of Lipids, Lipoproteins and Membranes 2008 Elsevier Science
8. T.M. Devlin Textbook of Biochemistry 1992 Wiley-Liss New York
9. D.J. Rader, J. Cohen, and H.H. Hobbs Monogenic hypercholesterolemia: new insights in pathogenesis and treatment J. Clin. Invest. 111 2003 1795 1803
10. J.M. Friedman Obesity in the new millennium Nature 404 2000 632 634
11. S. Jawalekar The hyperlipoproteinemia-an approach to diagnosis and classification Biochem Physiol. 1 2012 e105
12. B. Mittendorfer, B.W. Patterson, and S. Klein Effect of sex and obesity on basal VLDL-triacylglycerol kinetics Am. J. Clin. Nutr. 77 2003 573 579
13. A.D. Mooradian Dyslipidemia in type 2 diabetes mellitus Nat. Clin. Pract. Endocrinol. Metabol. 5 2009 150 159
14. M.J. Holzmann, I. Jungner, G. Walldius, T. Ivert, T. Nordqvist, J. Östergren, and N. Hammar Dyslipidemia is a strong predictor of myocardial infarction in subjects with chronic kidney disease Ann. Med. 44 2012 262 270
15. D.L. Longo, and T.R. Harrison Harrison's Principles of Internal Medicine 2012 McGraw-Hill Medical New York, N.Y. [etc.]
16. C.-Y. Dai, W.-L. Chuang, C.-K. Ho, M.-Y. Hsieh, J.-F. Huang, L.-P. Lee, N.-J. Hou, Z.-Y. Lin, S.-C. Chen, and M.-Y. Hsieh Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study J. Hepatol. 49 2008 9 16
17. I. Wakabayashi Relationships between alcohol intake and atherogenic indices in women J. Clin. Lipidol. 7 2013 454 462
18. E. Simo Camps, A. Orti Llaveria, F. Sena Ferrer, and E. Contreras Barbeta Blood cholesterol in patients with cancer An Med. Interna 15 1998 363 366
19. C.G. Alexopoulos, S. Pournaras, M. Vaslamatzis, A. Avgerinos, and S. Raptis Changes in serum lipids and lipoproteins in cancer patients during chemotherapy Cancer Chemother. Pharmacol. 30 1992 412 416
20. A.S. Raste, and P.P. Naik Clinical significance of lipid profile in cancer patients Indian J. Med. Sci. 54 2000 435 441
21. K. Siemianowicz, J. Gminski, M. Stajszczyk, W. Wojakowski, M. Goss, M. Machalski, A. Telega, K. Brulinski, and H. Magiera-Molendowska Serum HDL cholesterol concentration in patients with squamous cell and small cell lung cancer Int. J. Mol. Med. 6 2000 307 311
22. J.M. Halton, D.J. Nazir, M.J. McQueen, and R.D. Barr Blood lipid profiles in children with acute lymphoblastic leukemia Cancer 83 1998 379 384
23. I. Delimaris, E. Faviou, G. Antonakos, E. Stathopoulou, A. Zachari, and A. Dionyssiou-Asteriou Oxidized LDL, serum oxidizability and serum lipid levels in patients with breast or ovarian cancer Clin. Biochem. 40 2007 1129 1134
24. S. Muntoni, L. Atzori, R. Mereu, G. Satta, M.D. Macis, M. Congia, A. Tedde, and A. Desogus Serum lipoproteins and cancer Nutr. Metab. Cardiovasc. Dis. 19 2009 218 225
25. C. Alexopoulos, B. Blatsios, and A. Avgerinos Serum lipids and lipoprotein disorders in cancer patients Cancer 60 1987 3065 3070
26. M. Eichholzer, H.B. Stahelin, F. Gutzwiller, E. Ludin, and F. Bernasconi Association of low plasma cholesterol with mortality for cancer at various sites in men: 17-y follow-up of the prospective Basel study Am. J. Clin. Nutr. 71 2000 569 574
27. R. Wallace, C. Rost, L. Burmeister, and P. Pomrehn Cancer incidence in humans: relationship to plasma lipids and relative weight J. Natl. Cancer Inst. 68 1982 915 918
28. A.M. Strasak, R.M. Pfeiffer, L.J. Brant, K. Rapp, W. Hilbe, W. Oberaigner, S. Lang, W. Borena, H. Concin, G. Diem, E. Ruttmann, B. Glodny, K.P. Pfeiffer, and H. Ulmer Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172,210 men and women: a prospective 19-year follow-up study Ann. Oncol. 20 2009 1113 1120 official journal of the European Society for Medical Oncology/ESMO
29. R.A. Hiatt, and B.H. Fireman Serum cholesterol and the incidence of cancer in a large cohort J. Chronic Dis. 39 1986 861 870
30. H.B. Stähelin, F. Rösel, E. Buess, and G. Brubacher Cancer, vitamins, and plasma lipids: prospective Basel study J. Natl. Cancer Inst. 73 1984 1463 1468
31. A.M. Fiorenza, A. Branchi, and D. Sommariva Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects Int. J. Clin. Lab. Res. 30 2000 141 145
32. N. Forones, J. Falcao, D. Mattos, and B. Barone Cholesterolemia in colorectal cancer Hepato Gastroenterol. 45 1997 1531 1534
33. S. Strohmaier, M. Edlinger, J. Manjer, T. Stocks, T. Bjorge, W. Borena, C. Haggstrom, A. Engeland, G. Nagel, M. Almquist, R. Selmer, S. Tretli, H. Concin, G. Hallmans, H. Jonsson, P. Stattin, and H. Ulmer Total serum cholesterol and cancer incidence in the metabolic syndrome and Cancer Project (Me-Can) PloS One 8 2013 e54242
34. H. Iso, A. Ikeda, M. Inoue, S. Sato, and S. Tsugane Serum cholesterol levels in relation to the incidence of cancer: the JPHC study cohorts Int. J. Cancer 125 2009 2679 2686 J. Int. du cancer
35. R.R. Williams, P.D. Sorlie, M. Feinleib, P.M. McNamara, W.B. Kannel, and T.R. Dawber Cancer incidence by levels of cholesterol JAMA J. Am. Med. Assoc. 245 1981 247 252
36. I.A. Bani, C.M. Williams, P.S. Boulter, and J.W. Dickerson Plasma lipids and prolactin in patients with breast cancer Br. J. Cancer 54 1986 439 446
37. K. Hasija, and H.K. Bagga Alterations of serum cholesterol and serum lipoprotein in breast cancer of women Indian J. Clin. Biochem. 20 2005 61 66
38. K.E. Abdelsalam, I.K. Hassan, and I.A. Sadig The role of developing breast cancer in alteration of serum lipid profile J. Res. Med. Sci. 17 2012 562 565 the official journal of Isfahan University of Medical Sciences
39. S.A. Bhat, M.R. Mir, S. Majid, A.A. Reshi, I. Husain, T. Hassan, and H. Ahmad Serum lipid profile of breast cancer patients in Kashmir J. Invest. Biochem. 2 2013 26 31
40. G. Ray, and S.A. Husain Role of lipids, lipoproteins and vitamins in women with breast cancer Clin. Biochem. 34 2001 71 76
41. Y.L. Liu, H.X. Qian, L. Qin, X.J. Zhou, B. Zhang, and X. Chen Association of serum lipid profile with distant metastasis in breast cancer patients Zhonghua Zhong Liu Za Zhi. 34 2012 129 131 [Chinese journal of oncology]
42. L.J. Vatten, O.P. Foss, and S. Kvinnsland Overall survival of breast cancer patients in relation to preclinically determined total serum cholesterol, body mass index, height and cigarette smoking: a population-based study Eur. J. Cancer 27 1991 641 646
43. Y. Timovska, V. Pivnyuk, I. Todor, N. Anikusko, and V. Chekhun The spectrum of blood serum lipids in patients with breast cancer without metabolic syndrome Exp. Oncol. 33 2011 190 192
44. T. Agurs-Collins, K.S. Kim, G.M. Dunston, and L.L. Adams-Campbell Plasma lipid alterations in African-American women with breast cancer J. Cancer Res. Clin. Oncol. 124 1998 186 190
45. A.H. Eliassen, G.A. Colditz, B. Rosner, W.C. Willett, and S.E. Hankinson Serum lipids, lipid-lowering drugs, and the risk of breast cancer Arch. Intern. Med. 165 2005 2264 2271
46. M. Gaard, S. Tretli, and P. Urdal Risk of breast cancer in relation to blood lipids: a prospective study of 31,209 Norwegian women Cancer Causes Control CCC 5 1994 501 509
47. T.M. Elkhadrawy, H. Ahsan, and A.I. Neugut Serum cholesterol and the risk of ductal carcinoma in situ: a case-control study Eur. J. Cancer Prev. 7 1998 393 396
48. A.P. Hoyer, and G. Engholm Serum lipids and breast cancer risk: a cohort study of 5,207 Danish women Cancer Causes Control CCC 3 1992 403 408
49. A.M. Kucharska-Newton, W.D. Rosamond, P.J. Mink, A.J. Alberg, E. Shahar, and A.R. Folsom HDL-cholesterol and incidence of breast cancer in the ARIC cohort study Ann. Epidemiol. 18 2008 671 677
50. A.-S. Furberg, G. Jasienska, N. Bjurstam, P.A. Torjesen, A. Emaus, S.F. Lipson, P.T. Ellison, and I. Thune Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study Cancer Epidemiol. Biomarkers Prev. 14 2005 33 40
51. T. Tamura, S. Inagawa, K. Hisakura, T. Enomoto, and N. Ohkohchi Evaluation of serum high-density lipoprotein cholesterol levels as a prognostic factor in gastric cancer patients J. Gastroenterol. Hepatol. 27 2012 1635 1640
52. S. Dessi, B. Batetta, D. Pulisci, O. Spano, R. Cherchi, G. Lanfranco, L. Tessitore, P. Costelli, F.M. Baccino, and C. Anchisi et al. Altered pattern of lipid metabolism in patients with lung cancer Oncology 49 1992 436 441
53. P. Kumar, J. Augustine, A.B. Urs, S. Arora, S. Gupta, and V.R. Mohanty Serum lipid profile in oral cancer and leukoplakia: correlation with tobacco abuse and histological grading J. Cancer Res. Ther. 8 2012 384 388
54. R.J. Spiegel, E.J. Schaefer, I.T. Magrath, and B.K. Edwards Plasma lipid alterations in leukemia and lymphoma Am. J. Med. 72 1982 775 782
55. J.R. Peela The relationship between serum lipids and breast cancer in Libya Biochem. Anal. Biochem. 1 2012 1 3
56. M. Ferraroni, M. Gerber, A. Decarli, S. Richardson, E. Marubini, P. Crastes de Paulet, A. Crastes de Paulet, and H. Pujol HDL-cholesterol and breast cancer: a joint study in northern Italy and southern France Int. J. Epidemiol. 22 1993 772 780
57. P. Laisupasin, W. Thompat, S. Sukarayodhin, A. Sornprom, and Y. Sudjaroen Comparison of serum lipid profiles between Normal controls and breast Cancer patients J. Lab. Phys. 5 2013 38 41
58. M.H. Yang, S. Rampal, J. Sung, Y.-H. Choi, H.J. Son, J.H. Lee, Y.H. Kim, D.K. Chang, P.-L. Rhee, and J.J. Kim The association of serum lipids with colorectal Adenomas Am. J. Gastroenterol. 108 2013 833 841
59. C.C. Zielinski, I. Stuller, P. Rausch, and C. Muller Increased serum concentrations of cholesterol and triglycerides in the progression of breast cancer J. Cancer Res. Clin. Oncol. 114 1988 514 518
60. J.C. Melvin, D. Seth, L. Holmberg, H. Garmo, N. Hammar, I. Jungner, G. Walldius, M. Lambe, A. Wigertz, and M. Van Hemelrijck Lipid profiles and risk of breast and ovarian cancer in the Swedish AMORIS study Cancer Epidemiol. Biomarkers Prev. 21 2012 1381 1384
61. X. Yang, W. So, G.T. Ko, R.C. Ma, A.P. Kong, C.-C. Chow, P.C. Tong, and J.C. Chan Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus Can. Med. Assoc. J. 179 2008 427 437
62. T. Bjorge, A. Lukanova, H. Jonsson, S. Tretli, H. Ulmer, J. Manjer, T. Stocks, R. Selmer, G. Nagel, M. Almquist, H. Concin, G. Hallmans, C. Haggstrom, P. Stattin, and A. Engeland Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project Cancer Epidemiol. Biomarkers Prev. 19 2010 1737 1745 a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
63. Y. Kim, S.K. Park, W. Han, D.-H. Kim, Y.-C. Hong, E.H. Ha, S.-H. Ahn, D.-Y. Noh, D. Kang, and K.-Y. Yoo Serum high-density lipoprotein cholesterol and breast cancer risk by menopausal status, body mass index, and hormonal receptor in Korea Cancer Epidemiol. Biomarkers Prev. 18 2009 508 515
64. M. Knapp, S. al-Sheibani, and P. Riches Alterations of serum lipids in breast cancer: effects of disease activity, treatment, and hormonal factors Clin. Chem. 37 1991 2093 2101
65. Lovastatin 5-year safety and efficacy study. Lovastatin Study Groups I through IV Arch. Intern. Med. 153 1993 1079 1087
66. K.M. Dale, C.I. Coleman, N.N. Henyan, J. Kluger, and C.M. White Statins and cancer risk: a meta-analysis JAMA 295 2006 74 80
67. W.W. Wong, J. Dimitroulakos, M.D. Minden, and L.Z. Penn HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis Leukemia 16 2002 508 519
68. E.D. Flick, L.A. Habel, K.A. Chan, S.K. Van Den Eeden, V.P. Quinn, R. Haque, E.J. Orav, J.D. Seeger, M.C. Sadler, and C.P. Quesenberry Statin use and risk of prostate cancer in the California Men's Health Study cohort Cancer Epidemiol. Biomarkers Prev. 16 2007 2218 2225
69. G.D. Friedman, E.D. Flick, N. Udaltsova, J. Chan, C.P. Quesenberry, and L.A. Habel Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361 859 recipients Pharmacoepidemiol. Drug Saf. 17 2008 27 36
70. E.J. Jacobs, C. Rodriguez, E.B. Bain, Y. Wang, M.J. Thun, and E.E. Calle Cholesterol-lowering drugs and advanced prostate cancer incidence in a large US cohort Cancer Epidemiol. Biomarkers Prev. 16 2007 2213 2217
71. T.J. Murtola, T.L. Tammela, J. Lahtela, and A. Auvinen Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study Cancer Epidemiol. Biomarkers Prev. 16 2007 2226 2232
72. E.A. Platz, M.F. Leitzmann, K. Visvanathan, E.B. Rimm, M.J. Stampfer, W.C. Willett, and E. Giovannucci Statin drugs and risk of advanced prostate cancer J. Natl. Cancer Inst. 98 2006 1819 1825
73. D.M. Boudreau, O. Yu, D.S. Buist, and D.L. Miglioretti Statin use and prostate cancer risk in a large population-based setting Cancer Causes Control 19 2008 767 774
74. P.F. Coogan, L. Rosenberg, and B.L. Strom Statin use and the risk of 10 cancers Epidemiology 18 2007 213 219
75. M.R. Freeman, and K.R. Solomon Cholesterol and prostate cancer J. Cell. Biochem. 91 2004 54 69
76. E.A. Platz, S.K. Clinton, and E. Giovannucci Association between plasma cholesterol and prostate cancer in the PSA era Int. J. Cancer 123 2008 1693 1698
77. E.A. Platz, C. Till, P.J. Goodman, H.L. Parnes, W.D. Figg, D. Albanes, M.L. Neuhouser, E.A. Klein, I.M. Thompson, and A.R. Kristal Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial Cancer Epidemiol. Biomarkers Prev. 18 2009 2807 2813
78. J.A. Menendez, and R. Lupu Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis Nat. Rev. Cancer 7 2007 763 777
79. N.B. Kuemmerle, E. Rysman, P.S. Lombardo, A.J. Flanagan, B.C. Lipe, W.A. Wells, J.R. Pettus, H.M. Froehlich, V.A. Memoli, P.M. Morganelli, J.V. Swinnen, L.A. Timmerman, L. Chaychi, C.J. Fricano, B.L. Eisenberg, W.B. Coleman, and W.B. Kinlaw Lipoprotein lipase links dietary fat to solid tumor cell proliferation Mol. Cancer Ther. 10 2011 427 436
80. N. Zaidi, L. Lupien, N.B. Kuemmerle, W.B. Kinlaw, J.V. Swinnen, and K. Smans Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids Prog. Lipid Res. 52 2013 585 589
81. K. Brusselmans, L. Timmermans, T. Van de Sande, P.P. Van Veldhoven, G. Guan, I. Shechter, F. Claessens, G. Verhoeven, and J.V. Swinnen Squalene synthase, a determinant of Raft-associated cholesterol and modulator of cancer cell proliferation J. Biol. Chem. 282 2007 18777 18785
82. M.R. Freeman, D. Di Vizio, and K.R. Solomon The Rafts of the Medusa: cholesterol targeting in cancer therapy Oncogene 29 2010 3745 3747
83. L. Tatidis, M. Masquelier, and S. Vitols Elevated uptake of low density lipoprotein by drug resistant human leukemic cell lines Biochem. Pharmacol. 63 2002 2169 2180
84. D. Gal, M. Ohashi, P.C. MacDonald, H.J. Buchsbaum, and E.R. Simpson Low-density lipoprotein as a potential vehicle for chemotherapeutic agents and radionucleotides in the management of gynecologic neoplasms Am. J. Obstet. Gynecol. 139 1981 877 885
85. M.J. Rudling, E. Reihner, K. Einarsson, S. Ewerth, and B. Angelin Low density lipoprotein receptor-binding activity in human tissues: quantitative importance of hepatic receptors and evidence for regulation of their expression in vivo Proc. Natl. Acad. Sci. 87 1990 3469 3473
86. S. Vitols, C. Peterson, O. Larsson, P. Holm, and B. Åberg Elevated uptake of low density lipoproteins by human lung cancer tissue in vivo Cancer Res. 52 1992 6244 6247
87. S. Vitols, P. Gunvén, A. Gruber, and O. Larsson Expression of the low-density lipoprotein receptor, HMG-CoA reductase, and multidrug resistance (Mdr1) genes in colorectal carcinomas Biochem. Pharmacol. 52 1996 127 131
88. T.J. Murtola, H. Syvala, P. Pennanen, M. Blauer, T. Solakivi, T. Ylikomi, and T.L. Tammela The importance of LDL and cholesterol metabolism for prostate epithelial cell growth PloS One 7 2012 e39445
89. W. Riesen, G. Noseda, A. Morell, R. Butler, S. Barandun, and U.E. Nydegger Autoantibodies with antilipoprotein specificity and hypolipoproteinemia in patients with cancer Cancer Res. 35 1975 535 541
90. J.-R. Nofer, R. Junker, E. Pulawski, M. Fobker, B. Levkau, A. von Eckardstein, U. Seedorf, G. Assmann, and M. Walter High density lipoproteins induce cell cycle entry in vascular smooth muscle cells via mitogen activated protein kinase-dependent pathway Thromb. Haemost. 85 2001 730 735 Stuttgart-
91. D. McGrowder, C. Riley, E.Y.S.A. Morrison, and L. Gordon The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer Cholesterol 2011 2010
92. S.K. Das, S. Eder, S. Schauer, C. Diwoky, H. Temmel, B. Guertl, G. Gorkiewicz, K.P. Tamilarasan, P. Kumari, M. Trauner, R. Zimmermann, P. Vesely, G. Haemmerle, R. Zechner, and G. Hoefler Adipose triglyceride lipase contributes to cancer-associated cachexia Science 333 2011 233 238
93. C.R. Santos, and A. Schulze Lipid metabolism in cancer FEBS J. 279 2012 2610 2623
94. M. Mori, K. Yamaguchi, S. Honda, K. Nagasaki, M. Ueda, O. Abe, and K. Abe Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor Cancer Res. 51 1991 6656 6659
95. C. Gercel-Taylor, D.L. Doering, F.B. Kraemer, and D.D. Taylor Aberrations in normal systemic lipid metabolism in ovarian cancer patients Gynecol. Oncol. 60 1996 35 41
96. E. Kökolu, I. Karaarslan, H. Mehmet Karaarslan, and H. Balolu Alterations of serum lipids and lipoproteins in breast cancer Cancer Lett. 82 1994 175 178
97. F.W. Summerfield, and A.L. Tappel Determination by fluorescence quenching of the environment of DNA crosslinks made by malondialdehyde Biochim. Biophys. Acta BBA Gene Struct. Expr. 740 1983 185 189
98. L.J. Marnett, and M.A. Tuttle Comparison of the mutagenicities of malondialdehyde and the side products formed during its chemical synthesis Cancer Res. 40 1980 276 282
99. A. Kuchiba, T. Morikawa, M. Yamauchi, Y. Imamura, X. Liao, A.T. Chan, J.A. Meyerhardt, E. Giovannucci, C.S. Fuchs, and S. Ogino Body mass index and risk of colorectal cancer according to fatty acid synthase expression in the nurses' health study J. Natl. Cancer Inst. 104 2012 415 420
100. G.A. Mannes, A. Maier, C. Thieme, B. Wiebecke, and G. Paumgartner Relation between the frequency of colorectal adenoma and the serum cholesterol level N. Engl. J. Med. 315 1986 1634 1638
101. Z.-J. Sun, Y.-H. Huang, J.-S. Wu, Y.-C. Yang, Y.-F. Chang, F.-H. Lu, and C.-J. Chang The association of serum lipids with the histological pattern of rectosigmoid adenoma in Taiwanese adults BMC Gastroenterol. 11 2011 54
102. P.H. Gann, C.H. Hennekens, F.M. Sacks, F. Grodstein, E.L. Giovannucci, and M.J. Stampfer Prospective study of plasma fatty acids and risk of prostate cancer J. Natl. Cancer Inst. 86 1994 281 286
103. P. Henriksson, S. Ericsson, R. Stege, M. Eriksson, M. Rudling, L. Berglund, and B. Angelin Hypocholesterolaemia and increased elimination of low-density lipoproteins in metastatic cancer of the prostate Lancet 334 1989 1178 1180
104. S. Usui, K. Suzuki, H. Yamanaka, T. Nakano, K. Nakajima, Y. Hara, and M. Okazaki Estrogen treatment of prostate cancer increases triglycerides in lipoproteins as demonstrated by HPLC and immunoseparation techniques Clin. Chim. Acta 317 2002 133 143
105. K. Siemianowicz, J. Gminski, M. Stajszczyk, W. Wojakowski, M. Goss, M. Machalski, A. Telega, K. Brulinski, and H. Magiera-Molendowska Serum total cholesterol and triglycerides levels in patients with lung cancer Int. J. Mol. Med. 5 2000 201 205
106. K. Siemianowicz, J. Gminski, M. Stajszczyk, W. Wojakowski, M. Goss, M. Machalski, A. Telega, K. Brulinski, and H. Magiera-Molendowska Serum LDL cholesterol concentration and lipoprotein electrophoresis pattern in patients with small cell lung cancer Int. J. Mol. Med. 5 2000 55 62
107. N. Saito, T. Sairenchi, F. Irie, H. Iso, K. Iimura, H. Watanabe, T. Muto, and H. Ota Low serum LDL cholesterol levels are associated with elevated mortality from liver cancer in Japan: the Ibaraki Prefectural health study Tohoku J. Exp. Med. 229 2013 203 211
108. G. Ghosh, K.M. Jayaram, R.V. Patil, and S. Malik Alterations in serum lipid profile patterns in oral squamous cell carcinoma patients J. Contemp. Dent. Pract. 12 2011 451 456
109. V.K. Lohe, S.S. Degwekar, R.R. Bhowate, R.P. Kadu, and S.B. Dangore Evaluation of correlation of serum lipid profile in patients with oral cancer and precancer and its association with tobacco abuse J. Oral Pathol. Med. 39 2010 141 148 Official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
110. P.S. Patel, M.H. Shah, F.P. Jha, G.N. Raval, R.M. Rawal, M.M. Patel, J.B. Patel, and D.D. Patel Alterations in plasma lipid profile patterns in head and neck cancer and oral precancerous conditions Indian J. Cancer 41 2004 25 31
111. S. Baroni, D. Scribano, L. Pagano, C. Zuppi, G. Leone, and B. Giardina Lipids and lipoproteins in acute lymphoblastic leukaemia (ALL) Leuk. Res. 18 1994 643 644
112. S. Baroni, D. Scribano, C. Zuppi, L. Pagano, G. Leone, and B. Giardina Prognostic relevance of lipoprotein cholesterol levels in acute lymphocytic and nonlymphocytic leukemia Acta Haematol. 96 1996 24 28
113. A. Sh, and N. Fa Serum lipid profile alterations in acute leukemia before and after chemotherapy Iran. J. Blood Cancer 6 2013 3 9
114. I. Bani, C.M. Williams, P. Boulter, and J. Dickerson Plasma lipids and prolactin in patients with breast cancer Br. J. Cancer 54 1986 439
115. L.J. Vatten, K.S. Bjerve, A. Andersen, and E. Jellum Polyunsaturated fatty acids in serum phospholipids and risk of breast cancer: a case-control study from the Janus serum bank in Norway Eur. J. Cancer 29 1993 532 538
116. M. Thangaraju, K. Kumar, R. Gandhirajan, and P. Sachdanandam Effect of tamoxifen on plasma lipids and lipoproteins in postmenopausal women with breast cancer Cancer 73 1994 659 663
117. K. Hasija, and H.K. Bagga Alterations of serum cholesterol and serum lipoprotein in breast cancer of women Indian J. Clin. Biochem. IJCB 20 2005 61 66
118. M. Bahl, M. Ennis, I.F. Tannock, J.E. Hux, K.I. Pritchard, J. Koo, and P.J. Goodwin Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study Breast Cancer Res. Treat. 94 2005 135 144
119. P.J. Goodwin, N.F. Boyd, W. Hanna, W. Hartwick, D. Murray, A. Qizilbash, S. Redwood, N. Hood, M.E. DelGiudice, S. Sidlofsky, D. McCready, R. Wilkinson, L. Mahoney, P. Connelly, and D.L. Page Elevated levels of plasma triglycerides are associated with histologically defined premenopausal breast cancer risk Nutr. Cancer 27 1997 284 292
120. A.S. Furberg, M.B. Veierod, T. Wilsgaard, L. Bernstein, and I. Thune Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk J. Natl. Cancer Inst. 96 2004 1152 1160
121. L.E. Schreier, G.A. Berg, F.M. Basilio, G.I. Lopez, A.E. Etkin, and R.L. Wikinski Lipoprotein alterations, abdominal fat distribution and breast cancer Biochem. Mol. Biol. Int. 47 1999 681 690
122. S.A. Tornberg, L.E. Holm, and J.M. Carstensen Breast cancer risk in relation to serum cholesterol, serum beta-lipoprotein, height, weight, and blood pressure Acta Oncol. 27 1988 31 37
123. Y. Kim, S.K. Park, W. Han, D.H. Kim, Y.C. Hong, E.H. Ha, S.H. Ahn, D.Y. Noh, D. Kang, and K.Y. Yoo Serum high-density lipoprotein cholesterol and breast cancer risk by menopausal status, body mass index, and hormonal receptor in Korea Cancer Epidemiol. Biomarkers Prev. 18 2009 508 515 a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
124. V. Michalaki, G. Koutroulis, K. Syrigos, C. Piperi, and A. Kalofoutis Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer Mol. Cell. Biochem. 268 2005 19 24
125. K. Lindemann, L.J. Vatten, M. Ellstrom-Engh, and A. Eskild Serum lipids and endometrial cancer risk: results from the HUNT-II study Int. J. Cancer 124 2009 2938 2941 Journal international du cancer
126. D. Seth, H. Garmo, A. Wigertz, L. Holmberg, N. Hammar, I. Jungner, M. Lambe, G. Walldius, and M. Van Hemelrijck Lipid profiles and the risk of endometrial cancer in the Swedish AMORIS study Int. J. Mol. Epidemiol. Genet. 3 2012 122 133